Summary
Angiotensin II has many actions in the kidney, including regulation and distribution of renal circulation and glomerular filtration, as well as effects on mesangial contraction and on the filtration coefficient. The reduction in circulating and intrarenal angiotensin II by angiotensin converting enzyme (ACE) inhibitors in essential hypertension is associated with a significant increase in renal blood flow and a decrease in filtration fraction, without changes in glomerular filtration rate. In addition, administration of ACE inhibitors can reduce proximal sodium reabsorption via changes in peritubular hydrostatic and oncotic forces resulting from the fall in postglomerular capillary resistance. In severe hypertension the state of the renal vasculature does not allow ACE inhibition to induce similar haemodynamic changes and, therefore, it cannot contribute to renal sodium handling that requires the recruitment of alternate mechanisms. In spite of this, ACE inhibitors may exert a protective effect on the renal function of patients with severe hypertension as well as in those with renal impairment, by lowering systemic and, probably, intraglomerular pressure, reducing proteinuria and slowing the progression of renal failure.
Similar content being viewed by others
References
Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Journal of Clinical Investigation 77: 1993–2000, 1986
Blaufox MD, Merrill JP. Simplified hippuran clearance. Nephron 3: 273–281, 1966
deLeeuw PW, Hoogma RPLM, van Soest GAW, van Es PM, Birkenhager WH. Physiological effects of short-term treatment with enalapril in hypertensive patients. Journal of Hypertension 1 (Suppl. 1): 87–91, 1983
Edwards RM. Response of isolated renal microvessels to intraluminal pressure, norepinephrine and angiotensin II. Abstracts of the 15th Annual Meeting of the American Society of Nephrology, p. 150, Chicago, 1982
Hollenberg NK, Borucki LJ, Adams DF. The renal vasculature in early essential hypertension: evidence for a pathogenic role. Medicine 57: 167–168, 1978
London GM, Safar ME. Renal hemodynamics in patients with sustained essential hypertension and in patients with unilateral stenosis of the renal artery. American Journal of Hypertension 2: 244–252, 1989
Mimran A, Ribstein J. Angiotensin converting enzyme inhibitors and renal function. Journal of Hypertension 7 (Suppl. 5): 53–59, 1989
Navis GJ, de Zeeuw D, de Jong PE. Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation. Journal of Cardiovascular Pharmacology 8 (Suppl. 1): S30–S34, 1986
Schnurr E, Lahme W, Kuppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clinical Nephrology 13: 26–29, 1980
Simon G, Morioka S, Snyder DK, Cohn JN. Increased renal plasma flow during long-term treatment of essential hypertension with MK-421. Circulation 66: 166, 1982
Zimmermann BG, Wong PC. Alterations in renal function produced by angiotensin converting enzyme inhibitors. In Horovitz (Ed.) Angiotensin converting enzyme inhibitors, pp. 239–253, Urban & Schwarzenberg, Baltimore, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sánchez, R.A., Traballi, R.A., Marcó, C.J. et al. Effects of ACE Inhibition on Renal Haemodynamics in Essential Hypertension and Hypertension Associated with Chronic Renal Failure. Drugs 41 (Suppl 1), 25–30 (1991). https://doi.org/10.2165/00003495-199100411-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199100411-00006